Discover
BSX
Boston Scientific Corporation
43.06
1400 x undefined
900 x undefined
bid
ask
+
0.38
0.89%
1150 @ 06:16 AM
43.77 +0.71 (1.65%)
| Ytd | -54.84% | |
| 1y | -58.90% |
42.70
day range
43.76
42.25
52 week range
109.50
| Open | 43.21 | Prev Close | 42.68 | Low | 42.70 | High | 43.76 | Mkt Cap | 64.00B |
| Vol | 20.38M | Avg Vol | 20.41M | EPS | 2.39 | P/E | 18.02 | Forward P/E | 11.57 |
| Beta | 0.56 | Short Ratio | 1.33 | Inst. Own | 94.88% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-29 | 50-d Avg | 51.89 | 200-d Avg | 78.71 | 1yr Est | 75.00 |
| Income Statement | |||
| Total Revenue | 5.20B | ||
| Revenues (USD) | 5.20B | ||
| Cost of Revenue | 1.59B | ||
| Gross Profit | 3.61B | ||
| Operating Expenses | 2.51B | ||
| Research and Development Expense | 516.00M | ||
| Selling, General and Administrative Expense | 1.78B | ||
| Operating Income | 1.10B | ||
| Interest Expense | 90.00M | ||
| Income Tax Expense | -176.00M | ||
| Net Income | 1.34B | ||
| Net Income Common Stock | 1.34B | ||
| Net Income Common Stock (USD) | 1.34B | ||
| Consolidated Income | 1.34B | ||
| Net Income to Non-Controlling Interests | -2.00M | ||
| Earnings per Basic Share | 0.90 | ||
| Earnings per Basic Share (USD) | 0.90 | ||
| Earnings per Diluted Share | 0.90 | ||
| Earning Before Interest & Taxes (EBIT) | 1.25B | ||
| Earning Before Interest & Taxes (USD) | 1.25B | ||
| Weighted Average Shares | 1.48B | ||
| Weighted Average Shares Diluted | 1.50B | ||
| Balance Sheet | |||
| Cash and Equivalents | 1.45B | ||
| Cash and Equivalents (USD) | 1.45B | ||
| Trade and Non-Trade Receivables | 3.03B | ||
| Current Assets | 8.68B | ||
| Property, Plant & Equipment Net | 4.06B | ||
| Total Assets | 44.35B | ||
| Debt Current | 41.00M | ||
| Total Debt | 11.03B | ||
| Current Liabilities | 4.57B | ||
| Debt Non-Current | 10.99B | ||
| Total Liabilities | 18.25B | ||
| Accumulated Retained Earnings (Deficit) | 6.91B | ||
| Accumulated Other Comprehensive Income | -398.00M | ||
| Shareholders Equity | 25.86B | ||
| Shareholders Equity (USD) | 25.86B | ||
| Assets Non-Current | 35.67B | ||
| Total Debt (USD) | 11.03B | ||
| Goodwill and Intangible Assets | 25.60B | ||
| Inventory | 3.12B | ||
| Liabilities Non-Current | 13.68B | ||
| Trade and Non-Trade Payables | 1.14B | ||
| Tax Assets | 4.31B | ||
| Tax Liabilities | 219.00M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 351.00M | ||
| Net Cash Flow from Financing | -260.00M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -504.00M | ||
| Capital Expenditure | -177.00M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -462.00M | ||
| Issuance (Purchase) of Equity Shares | -4.00M | ||
| Issuance (Repayment) of Debt Securities | -259.00M | ||
| Net Cash Flow from Investing | -591.00M | ||
| Net Cash Flow from Operations | 348.00M | ||
| Share Based Compensation | 83.00M | ||